Alkane Resources Limited
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Nicolas Paul Earner
- Full Time Employees
- 105
- Sector
- Basic Materials
- Industry
- Gold
- Address
- 66 Kings Park Road West Perth WA Australia 6005
- IPO Date
- Feb 13, 2007
- Website
- alkane.com.au
- Similar Companies
- Business
- Alkane Resources Limited (ASX:ALK; TSX:ALK; OTCQX:ALKEF) operates as an Australia-based gold, antimony, and copper producer with producing assets and major development projects in Australia and Sweden; its wholly owned operations include the Tomingley Gold Operations, an open pit and underground gold mine southwest of Dubbo in Central West New South Wales producing approximately 60,000-70,000 ounces of gold annually; the Costerfield gold and antimony underground mining operation northeast of Heathcote in central Victoria featuring deposits such as Cuffley, Brunswick, Youle, and Shepherd; and the Björkdal underground gold mine northwest of Skellefteå in Sweden with ongoing east extension exploration; the company also owns the Boda-Kaiser gold-copper porphyry project north of Wellington in Central West New South Wales supported by a combined mineral resource of 8.3 million ounces of gold and 1.5 million tonnes of copper, alongside highly prospective gold and copper tenements including the Northern Molong Porphyry Project and near-mine regional exploration programs to grow resources. Founded in 1969 and headquartered in West Perth, Western Australia, Alkane sustains ongoing exploration and development across its portfolio targeting consistent production, cash generation, and resource expansion in premier mining jurisdictions. In August 2025, Alkane completed a merger of equals with Canada-based Mandalay Resources, creating a diversified producer with three operating mines, a proforma cash balance exceeding A$188 million, enhanced scale, liquidity, and financial strength to pursue organic growth, inorganic opportunities such as acquisitions, and advancement of the Boda-Kaiser project potentially through joint ventures. The merger integrates Mandalay's established Costerfield and Björkdal assets with Tomingley's ramp-up post-capital expansion, positioning the combined entity for valuation re-rating aligned with ASX peers and long-term strategy updates including consolidation in gold, antimony, and complementary metals.
Prediction markets favour Nvidia to stay on top despite Apple's charge
Alkane Resources delivers record FY26 cash flow and flags maiden dividend
The Small Cap Watch: Alkane delivers strong quarter; Hancock now 51% owner of Titan's Linderos Copper Project and Lightning advances Warby tungsten targets
FY26 Group production guidance delivered, record cashflow and maiden dividend proposed
Alkane Resources Provides Notice of Release of Q4 FY2026 Operating & Financial Results Webcast
Dow dips but Nasdaq higher after soft CPI and good bank earnings offset IBM shocker
Alkane Resources extends high-grade gold-antimony mineralisation at Brunswick South
Small Cap Watch: biotech, gold and critical minerals explorers deliver key milestones
Alkane Resources: A Cash-Rich Gold And Antimony Producer With Boda-Kaiser Upside
Alkane Extends High Grade Gold Trend at Brunswick South
Micron shares rise on $3B US semiconductor supply chain investment
Alkane hits high-grade gold in Björkdal near-mine drilling, strengthening growth case
Björkdal – Near Mine Exploration Update
Domino's expected to report weaker US sales in second quarter as investors look for recovery plans, UBS says
Nvidia backed by Bank of America as analysts see AI leadership supporting further growth
Shopify reinstated at Bank of America with ‘Buy’ rating on agentic commerce growth outlook
Alkane hits top half of FY26 guidance as cash climbs to $432 million
Apple expands Broadcom partnership with more than $30 billion US chipmaking commitment
Production in Top Half of FY2026 Guidance
Citi keeps AstraZeneca on 'buy' ahead of second-quarter results